According to Cara Therapeutics
's latest financial reports the company has HK$0.32 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | HK$0.78 B | -30.73% |
2022-12-31 | HK$1.13 B | -12.78% |
2021-12-31 | HK$1.30 B | -7.14% |
2020-12-31 | HK$1.40 B | 16.18% |
2019-12-31 | HK$1.20 B | -4.48% |
2018-12-31 | HK$1.26 B | 74.74% |
2017-12-31 | HK$0.72 B | 60.04% |
2016-12-31 | HK$0.45 B | -45.38% |
2015-12-31 | HK$0.82 B | 102.54% |
2014-12-31 | HK$0.40 B | 326.3% |
2013-12-31 | HK$95.82 M | 1006.72% |
2012-12-31 | HK$8.65 M | -72.79% |
2011-12-31 | HK$31.82 M |